Vertex Widens Patent Battle Against Lupin Over Cystic Fibrosis Drug

Vertex Pharmaceuticals has doubled down on its patent fight against Lupin over the company’s plan to market a generic version of Vertex’s cystic fibrosis treatment Kalydeco (ivacaftor).
Source: Drug Industry Daily